Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Leukemia, T-Cell

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Leukemia, T-Cell in 3 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Uddin, S1
Hussain, A1
Al-Hussein, K1
Platanias, LC1
Bhatia, KG1
Freeley, M1
Park, J1
Yang, KJ1
Wange, RL1
Volkov, Y1
Kelleher, D1
Long, A1
Häusler, P1
Papoff, G1
Eramo, A1
Reif, K1
Cantrell, DA1
Ruberti, G1

Other Studies

3 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Leukemia, T-Cell

ArticleYear
Inhibition of phosphatidylinositol 3'-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway.
    Biochemical and biophysical research communications, 2004, Jul-30, Volume: 320, Issue:3

    Topics: Apoptosis; Cell Line, Tumor; Chromones; Enzyme Inhibitors; Humans; Leukemia, T-Cell; Morpholines; Ph

2004
Loss of PTEN expression does not contribute to PDK-1 activity and PKC activation-loop phosphorylation in Jurkat leukaemic T cells.
    Cellular signalling, 2007, Volume: 19, Issue:12

    Topics: Androstadienes; Chromones; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Humans; Jurkat Cel

2007
Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B.
    European journal of immunology, 1998, Volume: 28, Issue:1

    Topics: Androstadienes; Animals; Apoptosis; Arabidopsis Proteins; Chromones; COS Cells; Enzyme Activation; E

1998